AU Patent

AU2006335994A1 — Nasal administration

Assigned to Optinose AS · Expires 2007-07-26 · 19y expired

What this patent protects

Patent listed against sumatriptan-succinate.

Drugs covered by this patent

sumatriptan-succinate (SUMATRIPTAN SUCCINATE)

Patent Metadata

Patent number: AU2006335994A1
Jurisdiction: AU
Classification: —
Expires: 2007-07-26
Drug substance claim: No
Drug product claim: No
Assignee: Optinose AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.